19 Views | 16 Downloads
Correspondence: Ursula A. Kelly, PhD, Joseph Maxwell Cleland Atlanta VA Medical Center and Nell Hodgson Woodruff School of Nursing, 1670 Clairmont Rd, Decatur, GA 30033 (ukelly@emory.edu; ursula.kelly@va.gov).
Author Contributions: Drs Kelly and Higgins had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Zaccari, Haywood, Patel, Emerson, Kelly. Acquisition, analysis, or interpretation of data: Zaccari, Higgins, Hubbard, Loftis, Kelly. Drafting of the manuscript: All authors. Critical review of the manuscript for important intellectual content: Zaccari, Higgins, Emerson, Hubbard, Loftis, Kelly. Statistical analysis: Higgins. Obtained funding: Kelly. Administrative, technical, or material support: Zaccari, Haywood, Emerson, Hubbard, Loftis. Supervision: Zaccari, Patel, Emerson, Loftis, Kelly.
Competing interests: Mr Emerson reported receiving grants from the Justice Resource Institute and a small amount of funding from the US Department of Veterans Affairs (VA) to cover a portion of his time during the conduct of the study. Dr Loftis reported receiving grants from the Department of Veterans Affairs Biomedical Laboratory Research and Development and National Institutes of Health during the conduct of the study and holding a patent for recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction (No. US 8 685 404 B2) licensed to Virogenomics BioDevelopment, Inc. No other disclosures were reported.
This study was funded by award I01 HX001087-02 from the VA Office of Research & Development, Health Services Research & Development (Dr Kelly). Additional support was received from the Learning Health Systems grant K12 HS026370 from the Agency for Healthcare Research and Quality (Dr Zaccari); Merit Review Award 5 I01 BX002061-06 from the VA Biomedical Laboratory Research and Development (Dr Loftis); and VA Health Services Research & Development Los Angeles Center of Innovation (project ID: CIN 13-417) for manuscript preparation.
2023 Zaccari B et al. JAMA Network Open.